|
生物種
|
リソース名
|
RRC ID
|
タイトル
|
ジャーナル
|
公開日
|
外部リンク
|
|
遺伝子材料
|
tFucci(CA)2/pCSII-EF (RDB15446)
|
85991
|
A histone-centric multi-omics study shows that increased H3K4 methylation sustains triple-negative breast cancer phenotypes.
|
Nat Commun |
2025-9-30 |
Pubmed
Full text
|
|
遺伝子材料
|
pCDNA3-DEGS1 (RDB20900)
,
pCDNA3-DEGS2 (RDB20901)
,
pCDNA3-HygR (RDB20899)
|
83326
|
Loss of function and reduced levels of sphingolipid desaturase DEGS1 variants are both relevant in disease mechanism.
|
J Lipid Res |
2024-3-1 |
Pubmed
Full text
|
|
遺伝子材料
|
miR-579/ZFR pGL3 (RDB20902)
|
83325
|
The MITF/mir-579-3p regulatory axis dictates BRAF-mutated melanoma cell fate in response to MAPK inhibitors.
|
Cell Death Dis |
2024-3-12 |
Pubmed
Full text
|
|
遺伝子材料
|
CSII-CMV-MCS-IRES2-Bsd (RDB04385)
|
78024
|
Aberrant MET activation impairs perinuclear actin cap organization with YAP1 cytosolic relocation.
|
Commun Biol |
2023-10-14 |
Pubmed
Full text
|
|
ヒト・動物細胞
,
遺伝子材料
|
II-18(RCB2093)
,
tFucci(CA)2/pCSII-EF (RDB15446)
|
76706
|
L858R emerges as a potential biomarker predicting response of lung cancer models to anti-EGFR antibodies: Comparison of osimertinib vs. cetuximab.
|
Cell Rep Med |
2023-8-3 |
Pubmed
Full text
|
|
遺伝子材料
|
8x3'Gli-BS-delta51-LucII (RDB08061)
|
54534
|
Novel GLI2 mutations identified in patients with Combined Pituitary Hormone Deficiency (CPHD): Evidence for a pathogenic effect by functional characterization.
|
Clin Endocrinol (Oxf) |
2019-3-1 |
Pubmed
Full text
|
|
遺伝子材料
|
pGL4-phPLAU (RDB07487)
,
pGL4-phSERPINE1(PAI-1) (RDB07461).
|
49319
|
HMGA1 regulates the Plasminogen activation system in the secretome of breast cancer cells.
|
Sci Rep |
2017-9-18 |
Pubmed
Full text
|
|
遺伝子材料
|
pGL4-phIL6 (RDB07313)
|
32716
|
Chromatin remodelling and autocrine TNFα are required for optimal interleukin-6 expression in activated human neutrophils.
|
Nat Commun |
2015-1-23 |
Pubmed
Full text
|
|
遺伝子材料
|
hTRAIL/pMKITneo (RDB02934)
|
30914
|
YM155 sensitizes triple-negative breast cancer to membrane-bound TRAIL through p38 MAPK- and CHOP-mediated DR5 upregulation.
|
Int J Cancer |
2015-1-15 |
Pubmed
Full text
|
|
遺伝子材料
|
pbovLIF (RDB01660)
|
29176
|
Ultrastructural and histochemical features of the ground substance in cyclosporin A-induced gingival overgrowth.
|
J Periodontol |
1996-1-1 |
Pubmed
Full text
|
|
遺伝子材料
|
pCMV-MAZ (RDB03219)
,
pGEX-hMAZ (RDB05701)
|
27186
|
MAZ-binding G4-decoy with locked nucleic acid and twisted intercalating nucleic acid modifications suppresses KRAS in pancreatic cancer cells and delays tumor growth in mice.
|
Nucleic Acids Res |
2013-4-1 |
Pubmed
Full text
|
|
遺伝子材料
|
pBMSA-NP (RDB01972)
|
27181
|
Heat-shock protein 70 from plant biofactories of recombinant antigens activate multiepitope-targeted immune responses.
|
Plant Biotechnol J |
2012-4-1 |
Pubmed
Full text
|
|
遺伝子材料
|
hTRAIL/pMKITneo (RDB02934)
|
21542
|
Surveillance of spontaneous breast cancer metastasis by TRAIL-expressing CD34⁺ cells in a xenograft model.
|
Breast Cancer Res Treat |
2012-11-1 |
Pubmed
Full text
|
|
遺伝子材料
|
pBluescript SKII+mIL10 (RDB01476)
|
21535
|
Development of an optimized tetracycline-inducible expression system to increase the accumulation of interleukin-10 in tobacco BY-2 suspension cells.
|
BMC Biotechnol |
2012-7-11 |
Pubmed
Full text
|
|
遺伝子材料
|
pCMV-SP1 (RDB04267)
,
pGEX-SP1 (RDB05699)
,
pGEX-hMAZ (RDB05701)
,
pCMV-MAZ (RDB03219).
|
12706
|
G4-DNA formation in the HRAS promoter and rational design of decoy oligonucleotides for cancer therapy.
|
PLoS One |
2011-1-1 |
Pubmed
Full text
|
|
遺伝子材料
|
hTRAIL/pMKITneo human TRAIL cDNA (RDB02934)
|
11945
|
Human CD34+ cells engineered to express membrane-bound tumor necrosis factor-related apoptosis-inducing ligand target both tumor cells and tumor vasculature.
|
Blood |
2010-3-18 |
Pubmed
Full text
|
|
遺伝子材料
|
pGEX-hMAZ (RDB03219)
,
pCMV-MAZ (RDB05701).
|
6867
|
The KRAS promoter responds to Myc-associated zinc finger and poly(ADP-ribose) polymerase 1 proteins, which recognize a critical quadruplex-forming GA-element.
|
J Biol Chem |
2010-7-16 |
Pubmed
Full text
|
|
遺伝子材料
|
pBluescript SKII+mIL10 (RDB01476)
|
5819
|
Viral and murine interleukin-10 are correctly processed and retain their biological activity when produced in tobacco.
|
BMC Biotechnol |
2009-3-19 |
Pubmed
Full text
|